Device Trial Radar · NCT05510661
Use of Export in Primary Percutaneous Coronary Intervention
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jan 15, 2024
Primary completion
Sep 24, 2025
Study completion Apr 17, 2026
Sponsor
- Lead sponsor
- National Institute of Cardiovascular Diseases, PakistanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- Aug 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.
Conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- Total Occlusion of Coronary Artery
- Primary Percutaneous Coronary Intervention
Interventions
Export CatheterDevice
Manual thrombus aspiration with the use of export catheter during primary PCI
Balloon catheterDevice
Predilatation with balloon catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post thrombus aspiration TIMI flowTime frame: Immediately after export/balloon
- Slow/No-reflowTime frame: Immediately after procedure
- Major adverse cardiac eventsTime frame: In-hospital, at 1 month, and at 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Institute of Cardiovascular Diseases
Karachi, Sindh, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.